Cited by 151DNA Repair MechanismsCancer therapeutics and mechanismsPARP inhibition in cancer therapy

Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA‐PK

Open access
Das, Benu Brata, Antony, Smitha, Gupta, Shalu, Dexheimer, Thomas S, Redon, Christophe E, Garfield, Susan, Shiloh, Yosef, Pommier, Yves·2009·The EMBO Journal

Abstract

Human tyrosyl-DNA phosphodiesterase (TDP1) hydrolyzes the phosphodiester bond at a DNA 3' end linked to a tyrosyl moiety. This type of linkage is found at stalled topoisomerase I (Top1)-DNA covalent complexes, and TDP1 has been implicated in the repair of such complexes. Here we show that Top1-associated DNA double-stranded breaks (DSBs) induce the phosphorylation of TDP1 at S81. This phosphorylation is mediated by the protein kinases: ataxia-telangiectasia-mutated (ATM) and DNA-dependent protein kinase (DNA-PK). Phosphorylated TDP1 forms nuclear foci that co-localize with those of phosphorylated histone H2AX (gammaH2AX). Both Top1-induced replication- and transcription-mediated DNA damages induce TDP1 phosphorylation. Furthermore, we show that S81 phosphorylation stabilizes TDP1, induces the formation of XRCC1 (X-ray cross-complementing group 1)-TDP1 complexes and enhances the mobilization of TDP1 to DNA damage sites. Finally, we provide evidence that TDP1-S81 phosphorylation promotes cell survival and DNA repair in response to CPT-induced DSBs. Together; our findings provide a new mechanism for TDP1 post-translational regulation by ATM and DNA-PK.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/emboj.2009.302

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ATM-dependent phosphorylation of TDP1 at serine 81 facilitates its recruitment to damage sites via XRCC1, promoting cell survival and DNA repair in HCT116 human colon carcinoma cells.

    “ATM-dependent TDP1 phosphorylation at Serine 81 facilitates its recruitment to damage sites via XRCC1, thereby promoting cell survival and DNA repair in the human colon carcinoma cell line HCT116 (Fig. 3) [170].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 72 · Cited by 151

Authors
Das, B. B., Antony, S., Gupta, S., Dexheimer, T. S., Redon, C. E., Garfield, S., Shiloh, Y., & Pommier, Y.
Affiliations
  • National Institutes of Health (US)
  • Tel Aviv University (IL)
Corresponding author
Pommier, Yves
Venue
The EMBO Journal
Published
2009-10-22
Volume
28
Issue
23
Pages
3667-3680
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2020692608
Cited by
151
References
72
Citations by year
2026: 3 · 2025: 7 · 2024: 8 · 2023: 8 · 2022: 6 · 2021: 12 · 2020: 11 · 2019: 10 · 2018: 10 · 2017: 9 · 2016: 9 · 2015: 14 · 2014: 11 · 2013: 10 · 2012: 9
FWCI
3.08
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Israel Cancer Research Fund
  • National Institutes of Health
  • National Cancer Institute
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
  • Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
Keywords
TDP1, tyrosyl-DNA phosphodiesterase, protein phosphorylation, ATM, DNA-dependent protein kinase, DNA double-strand breaks, topoisomerase I inhibition, γH2AX, XRCC1, protein stability, post-translational regulation, DNA repair, cell survival, camptothecin
MeSH terms
X-ray Repair Cross Complementing Protein 1, Ataxia Telangiectasia, Carnitine O-Palmitoyltransferase, Cell Survival, DNA Repair, DNA-Binding Proteins, Humans, Phosphoric Diester Hydrolases, Phosphorylation, Protein Processing, Post-Translational, Serine, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Tumor Suppressor Proteins, DNA-Activated Protein Kinase, DNA Breaks, Double-Stranded, Ataxia Telangiectasia Mutated Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review